MX2023015276A - Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1). - Google Patents
Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1).Info
- Publication number
- MX2023015276A MX2023015276A MX2023015276A MX2023015276A MX2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A
- Authority
- MX
- Mexico
- Prior art keywords
- varicose veins
- piezo1
- ion channel
- channel component
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163219462P | 2021-07-08 | 2021-07-08 | |
| PCT/US2022/073441 WO2023283560A1 (en) | 2021-07-08 | 2022-07-05 | Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023015276A true MX2023015276A (es) | 2024-04-03 |
Family
ID=82748409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023015276A MX2023015276A (es) | 2021-07-08 | 2022-07-05 | Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1). |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230041060A1 (https=) |
| EP (1) | EP4367266A1 (https=) |
| JP (1) | JP2024524554A (https=) |
| KR (1) | KR20240049797A (https=) |
| CN (1) | CN121175436A (https=) |
| AU (1) | AU2022307546A1 (https=) |
| CA (1) | CA3225855A1 (https=) |
| IL (1) | IL309694A (https=) |
| MX (1) | MX2023015276A (https=) |
| WO (1) | WO2023283560A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK4317456T3 (da) * | 2019-02-18 | 2025-09-08 | Regeneron Pharma | Varianter af mekanoensitiv ionkanalkomponent 1 af piezotypen (piezo1) og anvendelser deraf |
-
2022
- 2022-07-05 EP EP22748705.5A patent/EP4367266A1/en active Pending
- 2022-07-05 KR KR1020247004214A patent/KR20240049797A/ko active Pending
- 2022-07-05 CA CA3225855A patent/CA3225855A1/en active Pending
- 2022-07-05 IL IL309694A patent/IL309694A/en unknown
- 2022-07-05 WO PCT/US2022/073441 patent/WO2023283560A1/en not_active Ceased
- 2022-07-05 US US17/810,820 patent/US20230041060A1/en active Pending
- 2022-07-05 AU AU2022307546A patent/AU2022307546A1/en active Pending
- 2022-07-05 JP JP2024500281A patent/JP2024524554A/ja active Pending
- 2022-07-05 CN CN202280060862.6A patent/CN121175436A/zh active Pending
- 2022-07-05 MX MX2023015276A patent/MX2023015276A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023283560A1 (en) | 2023-01-12 |
| CA3225855A1 (en) | 2023-01-12 |
| JP2024524554A (ja) | 2024-07-05 |
| EP4367266A1 (en) | 2024-05-15 |
| AU2022307546A1 (en) | 2024-01-04 |
| IL309694A (en) | 2024-02-01 |
| CN121175436A (zh) | 2025-12-19 |
| US20230041060A1 (en) | 2023-02-09 |
| KR20240049797A (ko) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020154268A3 (en) | Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors | |
| BR112023021561A2 (pt) | Compostos de carbóxi-benzimidazol moduladores de glp-1r | |
| BR112022008817A2 (pt) | Terapias combinadas para tratamento de câncer | |
| MX2022011141A (es) | Anticuerpos anti-coronavirus y metodos de uso. | |
| BR112017021305A2 (pt) | dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva | |
| CY1105303T1 (el) | Ηλεκτροδιο βελονας | |
| MX2023009714A (es) | Metodos para el tratamiento de la perdida auditiva neurosensorial mediante el uso de sistemas de vectores duales de otoferlina. | |
| WO2019227096A8 (en) | Dynamic clamps and methods of use thereof | |
| AU2020225197A8 (en) | Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof | |
| PT1176971E (pt) | Utilizacao de phyllanthus para o tratamento de processos inflamatorios e fibroticos cronicos | |
| BR112021023473A2 (pt) | Vetores de terapia genética para osteopetrose maligna infantil | |
| DE60239012D1 (de) | Verfahren zum identifizieren von mustern in biologischen systemen und deren anwendungen | |
| BR112018067747A2 (pt) | proteínas de fusão recombinantes de folistatina-fc e uso no tratamento da distrofia muscular de duchenne | |
| BR112021006680A2 (pt) | sistema, método e dispositivo melhorados de tratamento de refluxo gastroesofágico | |
| BR112022006013A2 (pt) | Dispositivo e método para a determinação não inva-siva de analito | |
| MX2023015276A (es) | Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1). | |
| MX2022014254A (es) | Anticuerpos anti-hemojuvelina (hjv) para tratar mielofibrosis. | |
| EA202192176A1 (ru) | Нарушения, опосредованные интерфероном i типа | |
| BR112022008217A2 (pt) | Métodos e dispositivos para sequenciamento | |
| BR112022012477A2 (pt) | Método de ajuste, dispositivo móvel, programa de computador, meio de armazenamento legível por computador e kit | |
| EA202090439A1 (ru) | Способы и материалы для оценки и лечения рака | |
| WO2020190608A3 (en) | Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors | |
| MX2022013897A (es) | Dominio kelch que contiene variantes de 7b (klhdc7b) y usos de estas. | |
| MX2025008198A (es) | Terapia con moléculas de proteínas de unión a lípidos | |
| WO2023278787A3 (en) | Treatment of decreased bone mineral density with wnt family member 5b (wnt5b) inhibitors |